Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Nutr.

Sec. Nutrition and Metabolism

Volume 12 - 2025 | doi: 10.3389/fnut.2025.1632519

This article is part of the Research TopicHuman Milk, Nutrition and Infant Development, Volume IIView all 16 articles

Milk Fat Globule Membrane Supplementation in Formula Modulates the Gut Microbiome and Metabolic Status of Piglets and Normalizes Intestinal Development

Provisionally accepted
Zonghan  ZhouZonghan Zhou1Bin  LiuBin Liu2Jun  ShenJun Shen3Caihong  YanCaihong Yan3Guang  YangGuang Yang3Yu  ZhangYu Zhang1Junying  ZhaoJunying Zhao2Lijun  ChenLijun Chen2*
  • 1School of Food, Northeast Agricultural University, Harbin, Heilongjiang Province, China
  • 2National Engineering Research Center of Dairy Health for Maternal and Child, Beijing Sanyuan Foods Co., Ltd., Beijing, China
  • 3Beijing Commerce and Trade School Beijing Center for SPF Swine Breeding & Management, Beijing, China

The final, formatted version of the article will be published soon.

Milk fat globule membrane (MFGM) supplementation of infant formula demonstrates potential efficacy in modulating gut microbiota and metabolic profiles. However, the associated site-specific effects on intestinal microbial composition remain unclear. In this study, we used a neonatal piglet model to investigate the mechanisms associated with the metabolic regulation of supplemental MFGM and characterized the compartment-specific modulatory effects on intestinal microbial communities. A total of 20 piglets were randomly allotted to one of the following three groups: breastfed (BF), standard formula (SF), and MFGM-supplemented formula (EF). These diets were administered until weaning, with subsequent provision of commercial feed until euthanasia. Morphometric, microbial, and serum metabolomic analyses revealed that compared to piglets in the SF group, those in the EF group were characterized by significantly enhanced jejunal villus height (P < 0.05) and reduced cecal Oxalobacter (P < 0.05) and Pasteurella abundances, which were comparable to the levels detected in the BF group. Metabolically, piglets in the SF group demonstrated significantly lower levels of tyrosine, phenylalanine, and β-alanine (P < 0.05) and higher levels of 3-methyl-2-oxovalerate (P < 0.05) than those in BF piglets. In contrast, compared to the SF piglets, EF piglets exhibited significantly elevated levels of betaine (P < 0.05) and lysine. Spearman's correlation analysis revealed significant positive associations between Oxalobacter abundance and creatinine, dimethyl sulfone, phenylalanine, tyrosine, and β-alanine concentrations, with inverse correlations observed for 3-methyl-2-oxovalerate and lysine levels. In conclusion, these findings revealed that MFGM supplementation contributes to maintaining a normal intestinal architecture, modulates site-specific microbiota, and mitigates metabolic disparities between formula-fed and breastfed neonates. Notably, these effects are primarily mediated via choline pathway regulation and competitive inhibition of pathogenic bacteria.

Keywords: Milk fat globule membrane, Gut Microbiota, Metabolites, Intestinal development, Piglet

Received: 21 May 2025; Accepted: 01 Sep 2025.

Copyright: © 2025 Zhou, Liu, Shen, Yan, Yang, Zhang, Zhao and Chen. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Lijun Chen, National Engineering Research Center of Dairy Health for Maternal and Child, Beijing Sanyuan Foods Co., Ltd., Beijing, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.